Who uses Bruker GeoMx?
GeoMx profiles RNA or protein from regions a researcher picks on a tissue slide, such as a tumor's edge or a cluster of immune cells. It's made by Bruker Spatial Biology (formerly NanoString). 173 bioRxiv and medRxiv preprints since April 2025 say they used GeoMx, 47 in the last 6 months. Updated daily (as of Nov 16)
Is GeoMx use still growing?
No: 47 preprints used GeoMx in Jun–Nov 2026, -25% vs the previous year as a share of all preprints. This is slower than spatial biology platforms overall (+35%).
The last bar is the quarter so far. The % over each year compares it with the year before, as a share of all preprints.
How does GeoMx compare with other spatial biology platforms?
GeoMx is third, with 10% of their uses in Jun–Nov 2026, down from 18% the year before. Visium leads with 37%.
Which institutions use GeoMx most?
The institutions using GeoMx most are University of California, San Francisco, Johns Hopkins University and University of Glasgow.
Institutions
University of California, San Francisco6
Johns Hopkins University5
University of Glasgow3
University of Alabama at Birmingham3
Mayo Clinic3
Where the labs are
The lab's institution and country are the corresponding author's.
Rival platforms, head to head
Latest preprints using GeoMx
Who started using GeoMx recently?
26 institutions posted their first preprint using GeoMx since April 2025 in the last 6 months, including University of Washington, McGill University and University of Minnesota.
University of WashingtonJun 11, 2026
McGill UniversityJul 16, 2026
University of MinnesotaAug 10, 2026
- City of HopeOct 5, 2026
UPMC Hillman Cancer CenterJun 16, 2026
Vanderbilt UniversityJun 17, 2026
Tennessee Valley Healthcare SystemJun 20, 2026
University of North DakotaJun 25, 2026
Aarhus UniversityJul 7, 2026
- Bioinformatics InstituteJul 13, 2026
An institution counts as new when its first preprint using GeoMx since April 2025 was posted in the last 6 months; the date is that first preprint.
What do labs use alongside GeoMx?
Preprints using GeoMx most often also use NextSeq, Chromium and NovaSeq X. The count is preprints using both.
What is GeoMx used for?
Preprints using GeoMx are most often in cancer biology, neuroscience and immunology.
Fields
Cancer biology 50Neuroscience 27Immunology 24Cell biology 13Bioengineering 8Pathology 7
Where the work was published
- Nature Communications2
- JCI Insight2
- Neurobiology of Disease2
- Cancer Cell1
- Journal of Neuroinflammation1
- Microbiology1
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.